66 results
Page 3 of 4
8-K
EX-99.1
3cn r6y90
5 Nov 19
Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
7:15am
8-K
EX-99.1
fkcs0b63fsuyq7x63
1 Aug 19
Viking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:24pm
8-K
EX-99.1
n7v8l9 q0mmdqi
2 May 19
Viking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
4:05pm
8-K
EX-99.1
fi0ekibf1a5gsyj5u
13 Mar 19
Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
4:12pm
CORRESP
jmvlfgci7sdn
17 Jul 18
Correspondence with SEC
12:00am
8-K
EX-1.1
kz3ndb k3qy2zuxryk
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm